{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-004833","form_type":"8-K","ticker":"MCRB","cik":"0001609809","company_name":"Seres Therapeutics, Inc.","filed_at":"2024-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.802527+00:00","generated_at":"2026-06-07T01:30:55.266308+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Seres Therapeutics posts updated corporate presentation; no specific new financial or operational data disclosed","bullets":["Company filed an 8-K on Jan 9, 2024 to disclose an updated corporate presentation.","Presentation posted on Seres' investor relations website; no financial results or guidance provided.","Exhibit 99.1 text truncated; full presentation content not available for review.","Filing is a routine Regulation FD disclosure with no material new information."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-004833","json":"https://secwatch.observer/filing/0001193125-24-004833.json","markdown":"https://secwatch.observer/filing/0001193125-24-004833.md","text":"https://secwatch.observer/filing/0001193125-24-004833.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1609809/000119312524004833/0001193125-24-004833-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1609809/000119312524004833/d90190d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T01:30:55.266308+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}